Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone (Q72190826)
Jump to navigation
Jump to search
scientific article published on 01 May 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone |
scientific article published on 01 May 1994 |
Statements
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone (English)
Adami S
Zamberlan N
Mian M
Dorizzi R
Rossini M
Braga B
Gatti D
Bertoldo F